Clinical Examples of the Use of Mercureid Drug in Patients with Ischemic Neuropathy of the Optic Nerve That Appeared After Long COVID-19

Gusev, S. N.; Velichko, L. N.; Bogdanova, A. V.; Khramenko, N. I.; Konovalova, N. V.; Kovtun, A. V.

dc.contributor.author	Gusev, S. N.	en
dc.contributor.author	Velichko, L. N.	en
dc.contributor.author	Bogdanova, A. V.	en
dc.contributor.author	Khramenko, N. I.	en
dc.contributor.author	Konovalova, N. V.	en
dc.contributor.author	Kovtun, A. V.	en
dc.date.accessioned	2022-12-12T12:34:58Z
dc.date.available	2022-12-12T12:34:58Z
dc.date.issued	2021
dc.identifier.citation	Gusev SN, et al. Clinical Examples of the Use of Mercureid Drug in Patients with Ischemic Neuropathy of the Optic Nerve That Appeared After Long COVID-19. Jour Clin Med Res. 2021;2(3) :1- 9. DOI: http://dx.doi.org/10.46889/JCMR.2021.2301	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/11754
dc.description.abstract	Most people with coronavirus disease 2019 (COVID-19) recover completely within a few weeks. But some people continue to experience symptoms after the initial recovery. This condition is called post-COVID-19 syndrome or long COVID-19. They are threatened by the development of various diseases. We tried to answer some of these questions in our research. The study was conducted in 49 patients with ophthalmic pathologies who had previously undergone COVID-19. On the one hand, ocular pathologies are important because they allow in a non-traumatic way to obtain lifetime visualization of the state of blood vessels and capillaries as well as to assess the effect of the virus on the central nervous system.	en
dc.language.iso	en	en
dc.subject	Pupil	en
dc.subject	Optic Neuritis	en
dc.subject	Optical Coherence Tomography	en
dc.subject	Cornea	en
dc.title	Clinical Examples of the Use of Mercureid Drug in Patients with Ischemic Neuropathy of the Optic Nerve That Appeared After Long COVID-19	en
dc.type	Article	en